Bausch Health Companies (BHC) Cash from Operations (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Cash from Operations came in at 230000000.0 in Q1 2026, up 9.0% year-on-year from 211000000.0 in Q1 2025, and down 53.54% quarter-over-quarter from 495000000.0 in Q4 2025.
Bausch Health Companies (BHC) Cash from Operations (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Cash from Operations across 18 years of filings, most recently posting 230000000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 230000000.0, up 9.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1419000000.0 (down 11.15% YoY), and the FY2025 annual result was 1400000000.0, down 12.34% from the prior year.
- Cash from Operations came in at 230000000.0 for Q1 2026 at Bausch Health Companies, down from 495000000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 601000000.0 in Q4 2024 to a low of 1263000000.0 in Q3 2022.
- The 5-year median for Cash from Operations is 282000000.0 (2023), against an average of 207705882.35.
- Peak annual rise in Cash from Operations reached 1879.17% in 2022, while the deepest fall reached 323.94% in 2022.
- Bausch Health Companies' Cash from Operations stood at 475000000.0 in 2022, then slipped by 17.89% to 390000000.0 in 2023, then surged by 54.1% to 601000000.0 in 2024, then declined by 17.64% to 495000000.0 in 2025, then sank by 53.54% to 230000000.0 in 2026.
- The last three Cash from Operations figures came in at 230000000.0 (Q1 2026), 495000000.0 (Q4 2025), and 405000000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 230.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230.00 Mn |
| Mar 31, 2026 | 230.00 Mn |
| Dec 31, 2025 | 495.00 Mn |
| Dec 31, 2025 | 495.00 Mn |
| Sep 30, 2025 | 405.00 Mn |
| Sep 30, 2025 | 405.00 Mn |
| Jun 30, 2025 | 289.00 Mn |
| Jun 30, 2025 | 289.00 Mn |
| Mar 31, 2025 | 211.00 Mn |
| Mar 31, 2025 | 211.00 Mn |
| Dec 31, 2024 | 601.00 Mn |
| Dec 31, 2024 | 601.00 Mn |
| Sep 30, 2024 | 405.00 Mn |
| Sep 30, 2024 | 405.00 Mn |
| Jun 30, 2024 | 380.00 Mn |
| Jun 30, 2024 | 380.00 Mn |
| Mar 31, 2024 | 211.00 Mn |
| Mar 31, 2024 | 211.00 Mn |
| Dec 31, 2023 | 390.00 Mn |
| Dec 31, 2023 | 390.00 Mn |